These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2463383)

  • 1. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.
    Salfeld J; Pfaff E; Noah M; Schaller H
    J Virol; 1989 Feb; 63(2):798-808. PubMed ID: 2463383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly.
    Schödel F; Peterson D; Zheng J; Jones JE; Hughes JL; Milich DR
    J Biol Chem; 1993 Jan; 268(2):1332-7. PubMed ID: 8419335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
    J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant.
    Sällberg M; Rudén U; Wahren B; Noah M; Magnius LO
    Mol Immunol; 1991 Jul; 28(7):719-26. PubMed ID: 1713295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
    Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G
    J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
    Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
    J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies.
    Colucci G; Beazer Y; Cantaluppi C; Tackney C
    J Immunol; 1988 Dec; 141(12):4376-80. PubMed ID: 2461991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes recognized by antibodies to denatured core protein of hepatitis B virus.
    Bichko V; Schödel F; Nassal M; Gren E; Berzinsh I; Borisova G; Miska S; Peterson DL; Gren E; Pushko P
    Mol Immunol; 1993 Feb; 30(3):221-31. PubMed ID: 7679466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    J Med Virol; 1994 Jan; 42(1):7-15. PubMed ID: 7508491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBc and HBe specificity of monoclonal antibodies against complete and truncated HBc proteins from E. coli.
    Korec E; Gerlich WH
    Arch Virol Suppl; 1992; 4():119-21. PubMed ID: 1280501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and monoclonal antibodies to hepatitis B core antigen recognise a single immunodominant epitope.
    Ferns RB; Tedder RS
    J Med Virol; 1986 Jun; 19(2):193-203. PubMed ID: 2425050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen.
    Hojatizadeh M; Amiri MM; Mobini M; Hassanzadeh Makoui M; Ghaedi M; Ghotloo S; Peyghami K; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Viral Immunol; 2023; 36(6):378-388. PubMed ID: 37294935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
    Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
    J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
    Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
    J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunogenicity of hepatitis B virus core and E antigens.
    Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
    J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intramolecular disulfide bridge between Cys-7 and Cys61 determines the structure of the secretory core gene product (e antigen) of hepatitis B virus.
    Nassal M; Rieger A
    J Virol; 1993 Jul; 67(7):4307-15. PubMed ID: 8510224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of the immunogenicity of hepatitis B core antigen in a hepatitis B e antigen polypeptide (P19).
    Takahashi K; Imai M; Nomura M; Oinuma A; Machida A; Funatsu G; Miyakawa Y; Mayumi M
    J Gen Virol; 1981 Dec; 57(Pt 2):325-30. PubMed ID: 6172555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection.
    Wang SJ; Chen ZM; Wei M; Liu JQ; Li ZL; Shi TS; Nian S; Fu R; Wu YT; Zhang YL; Wang YB; Zhang TY; Zhang J; Xiong JH; Tong SP; Ge SX; Yuan Q; Xia NS
    Emerg Microbes Infect; 2021 Dec; 10(1):37-50. PubMed ID: 33296295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.